UNC Health Cancer Care Raleigh — Raleigh, North Carolina

UNC Health Cancer Care Raleigh is a clinical research site located in Raleigh, North Carolina, United States 27607.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

UNC Health Cancer Care Raleigh has participated in 17 clinical trials with 16 currently active.

Therapeutic areas: Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Margin Squamous Cell Carcinoma.

Sponsors: National Cancer Institute (NCI), NRG Oncology, Alliance for Clinical Trials in Oncology.

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UNC Health Cancer Care Raleigh?

UNC Health Cancer Care Raleigh has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UNC Health Cancer Care Raleigh conducted?

UNC Health Cancer Care Raleigh has 17 clinical trials on record, with 16 currently active. Their work covers Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Margin Squamous Cell Carcinoma.

Is UNC Health Cancer Care Raleigh accredited by Crixeo Health?

Yes — UNC Health Cancer Care Raleigh holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about UNC Health Cancer Care Raleigh?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.